Focus: CMP Pharma is a small-molecule pharmaceutical company founded in 1975, headquartered in Farmville, NC, with a focused portfolio in nephrology, immunology, and infectious diseases. The company operates primarily in the generic and ANDA space with established branded products.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
CMP Pharma represents a stable but stagnant generics operation with minimal career growth opportunities; suitable only for professionals seeking commodity pharmaceutical experience without innovation or advancement potential.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Established generic product in nephrology; off-patent with commodity pricing pressures.
Help build intelligence for CMP Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from CMP Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Post-LOE corticosteroid for nasal allergy symptoms; mature market with generic competition.
Off-patent corticosteroid with limited differentiation in crowded immunology market.
Essential tuberculosis treatment with stable demand in infectious disease; commodity pricing.
1 discontinued, 1 duplicate formulations not shown
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo